9.56 USD
▲-0.06+4.48%
盘后 9.20 +0.55%
2026-08-03
市值
$517.57M
市盈率
—
EPS
-32.19
股息率
—
52 周区间
7.90 – 17.40
成交量
395.94K
Beta
—
目标价
24.80
52W 低 7.9052W 高 17.40
价格走势
公司简介
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent W...